Rank | Gene Set | Z-score |
---|---|---|
1 | COPI coating of Golgi vesicle (GO:0048205) | 4.60386522 |
2 | Golgi transport vesicle coating (GO:0048200) | 4.60386522 |
3 | alpha-linolenic acid metabolic process (GO:0036109) | 4.26881981 |
4 | regulation of cholesterol homeostasis (GO:2000188) | 4.17274672 |
5 | L-phenylalanine catabolic process (GO:0006559) | 4.11710608 |
6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.11710608 |
7 | urea metabolic process (GO:0019627) | 3.96024461 |
8 | urea cycle (GO:0000050) | 3.96024461 |
9 | L-phenylalanine metabolic process (GO:0006558) | 3.89311889 |
10 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.89311889 |
11 | negative regulation of fibrinolysis (GO:0051918) | 3.78919565 |
12 | cell-substrate junction assembly (GO:0007044) | 3.77788244 |
13 | cell-substrate adherens junction assembly (GO:0007045) | 3.77664021 |
14 | focal adhesion assembly (GO:0048041) | 3.77664021 |
15 | sulfur amino acid catabolic process (GO:0000098) | 3.76730476 |
16 | adherens junction assembly (GO:0034333) | 3.75896000 |
17 | regulation of histone H3-K27 methylation (GO:0061085) | 3.73011264 |
18 | hemidesmosome assembly (GO:0031581) | 3.68313936 |
19 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.67938582 |
20 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.66517877 |
21 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.64689676 |
22 | protein carboxylation (GO:0018214) | 3.64689676 |
23 | lysine catabolic process (GO:0006554) | 3.63457096 |
24 | lysine metabolic process (GO:0006553) | 3.63457096 |
25 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.61571631 |
26 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.61352011 |
27 | mannose metabolic process (GO:0006013) | 3.60134859 |
28 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.60076147 |
29 | complement activation, alternative pathway (GO:0006957) | 3.59396751 |
30 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.57611062 |
31 | aromatic amino acid family catabolic process (GO:0009074) | 3.51696823 |
32 | protein localization to endosome (GO:0036010) | 3.50255541 |
33 | intestinal cholesterol absorption (GO:0030299) | 3.47639672 |
34 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 3.46485404 |
35 | homocysteine metabolic process (GO:0050667) | 3.45566125 |
36 | kynurenine metabolic process (GO:0070189) | 3.44708470 |
37 | nitrogen cycle metabolic process (GO:0071941) | 3.43119352 |
38 | cysteine metabolic process (GO:0006534) | 3.42331066 |
39 | positive regulation of nuclease activity (GO:0032075) | 3.42006142 |
40 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.39552408 |
41 | regulation of protein activation cascade (GO:2000257) | 3.39068053 |
42 | histone H3-K36 demethylation (GO:0070544) | 3.38884122 |
43 | regulation of NFAT protein import into nucleus (GO:0051532) | 3.36321336 |
44 | phospholipid homeostasis (GO:0055091) | 3.33547861 |
45 | negative regulation of sterol transport (GO:0032372) | 3.32180797 |
46 | negative regulation of cholesterol transport (GO:0032375) | 3.32180797 |
47 | macroautophagy (GO:0016236) | 3.31464920 |
48 | negative regulation of cell size (GO:0045792) | 3.30308208 |
49 | valine metabolic process (GO:0006573) | 3.30037769 |
50 | positive regulation of histone deacetylation (GO:0031065) | 3.28409545 |
51 | desmosome organization (GO:0002934) | 3.27824406 |
52 | regulation of fibrinolysis (GO:0051917) | 3.27038515 |
53 | negative regulation of fatty acid transport (GO:2000192) | 3.25965691 |
54 | glucocorticoid receptor signaling pathway (GO:0042921) | 3.25277757 |
55 | * COPII vesicle coating (GO:0048208) | 3.24250573 |
56 | high-density lipoprotein particle remodeling (GO:0034375) | 3.21081722 |
57 | regulation of complement activation (GO:0030449) | 3.20745934 |
58 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 3.19975256 |
59 | semaphorin-plexin signaling pathway (GO:0071526) | 3.18314277 |
60 | 4-hydroxyproline metabolic process (GO:0019471) | 3.16453172 |
61 | activation of Rac GTPase activity (GO:0032863) | 3.13763033 |
62 | reverse cholesterol transport (GO:0043691) | 3.13634090 |
63 | 2-oxoglutarate metabolic process (GO:0006103) | 3.13088479 |
64 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 3.12932414 |
65 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.11959925 |
66 | endoplasmic reticulum unfolded protein response (GO:0030968) | 3.10348434 |
67 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.09725342 |
68 | regulation of nuclease activity (GO:0032069) | 3.08168975 |
69 | tryptophan metabolic process (GO:0006568) | 3.05260562 |
70 | tryptophan catabolic process (GO:0006569) | 3.04482542 |
71 | indole-containing compound catabolic process (GO:0042436) | 3.04482542 |
72 | indolalkylamine catabolic process (GO:0046218) | 3.04482542 |
73 | bile acid biosynthetic process (GO:0006699) | 3.02723109 |
74 | basement membrane organization (GO:0071711) | 3.02397558 |
75 | positive regulation of glycolytic process (GO:0045821) | 3.01986607 |
76 | response to laminar fluid shear stress (GO:0034616) | 3.01554890 |
77 | intracellular estrogen receptor signaling pathway (GO:0030520) | 3.01228041 |
78 | glyoxylate metabolic process (GO:0046487) | 3.00661600 |
79 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.98834457 |
80 | cellular modified amino acid catabolic process (GO:0042219) | 2.97507965 |
81 | cellular response to unfolded protein (GO:0034620) | 2.97346833 |
82 | serine family amino acid catabolic process (GO:0009071) | 2.97178159 |
83 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.96518028 |
84 | embryonic process involved in female pregnancy (GO:0060136) | 2.94981451 |
85 | acylglycerol homeostasis (GO:0055090) | 2.94942362 |
86 | triglyceride homeostasis (GO:0070328) | 2.94942362 |
87 | ER-nucleus signaling pathway (GO:0006984) | 2.94026382 |
88 | phospholipid efflux (GO:0033700) | 2.92493262 |
89 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.92154479 |
90 | plasma lipoprotein particle clearance (GO:0034381) | 2.91472759 |
91 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.90376932 |
92 | apoptotic process involved in morphogenesis (GO:0060561) | 2.89866617 |
93 | low-density lipoprotein particle clearance (GO:0034383) | 2.89308710 |
94 | maternal placenta development (GO:0001893) | 2.89148704 |
95 | regulation of triglyceride catabolic process (GO:0010896) | 2.88872635 |
96 | negative regulation of lipid transport (GO:0032369) | 2.87855032 |
97 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.87685630 |
98 | hormone catabolic process (GO:0042447) | 2.87459591 |
99 | regulation of RNA export from nucleus (GO:0046831) | 2.87127900 |
100 | bile acid metabolic process (GO:0008206) | 2.86923784 |
101 | endothelial cell chemotaxis (GO:0035767) | 2.86597567 |
102 | lipoprotein metabolic process (GO:0042157) | 2.86018210 |
103 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.85182858 |
104 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.84611367 |
105 | positive regulation of transcription from RNA polymerase III promoter (GO:0045945) | 2.83365381 |
106 | exocrine pancreas development (GO:0031017) | 2.83109689 |
107 | corticosteroid receptor signaling pathway (GO:0031958) | 2.81624294 |
108 | intestinal absorption (GO:0050892) | 2.79993433 |
109 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.79693302 |
110 | regulation of early endosome to late endosome transport (GO:2000641) | 2.79688632 |
111 | growth hormone receptor signaling pathway (GO:0060396) | 2.79563405 |
112 | positive regulation of lipid catabolic process (GO:0050996) | 2.77481221 |
113 | plasma lipoprotein particle assembly (GO:0034377) | 2.76767466 |
114 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.76760109 |
115 | protein-lipid complex assembly (GO:0065005) | 2.76153205 |
116 | epithelial cell-cell adhesion (GO:0090136) | 2.75703936 |
117 | tricarboxylic acid metabolic process (GO:0072350) | 2.74759694 |
118 | tyrosine metabolic process (GO:0006570) | 2.74440241 |
119 | bile acid and bile salt transport (GO:0015721) | 2.73859527 |
120 | fatty acid transmembrane transport (GO:1902001) | 2.73696032 |
121 | regulation of ARF protein signal transduction (GO:0032012) | 2.72578741 |
122 | positive regulation of fatty acid oxidation (GO:0046321) | 2.72116453 |
123 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.71911099 |
124 | apoptotic cell clearance (GO:0043277) | 2.71211340 |
125 | cellular response to topologically incorrect protein (GO:0035967) | 2.70978756 |
126 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.70670321 |
127 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.68934994 |
128 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.68365144 |
129 | amino-acid betaine metabolic process (GO:0006577) | 2.67237448 |
130 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.67115229 |
131 | protein retention in ER lumen (GO:0006621) | 2.67004455 |
132 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.66529467 |
133 | atrioventricular valve morphogenesis (GO:0003181) | 2.65361902 |
134 | skin morphogenesis (GO:0043589) | 2.64015574 |
135 | embryonic eye morphogenesis (GO:0048048) | 2.62614539 |
136 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.62181560 |
137 | plasma lipoprotein particle remodeling (GO:0034369) | 2.61508676 |
138 | protein-lipid complex remodeling (GO:0034368) | 2.61508676 |
139 | macromolecular complex remodeling (GO:0034367) | 2.61508676 |
140 | fatty acid homeostasis (GO:0055089) | 2.61060227 |
141 | cholesterol efflux (GO:0033344) | 2.60404104 |
142 | carnitine shuttle (GO:0006853) | 2.58425520 |
143 | regulation of extracellular matrix disassembly (GO:0010715) | 2.58313706 |
144 | embryonic camera-type eye morphogenesis (GO:0048596) | 2.57435844 |
145 | regulation of water loss via skin (GO:0033561) | 2.57280203 |
146 | stress fiber assembly (GO:0043149) | 2.56819387 |
147 | histone lysine demethylation (GO:0070076) | 2.56601595 |
148 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.55045418 |
149 | cholesterol homeostasis (GO:0042632) | 2.53971025 |
150 | alpha-amino acid catabolic process (GO:1901606) | 2.53742345 |
151 | sterol homeostasis (GO:0055092) | 2.53737472 |
152 | regulation of endothelial cell chemotaxis (GO:2001026) | 2.52291828 |
153 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.49794892 |
154 | hypotonic response (GO:0006971) | 2.45267152 |
155 | histone demethylation (GO:0016577) | 2.44781112 |
156 | cellular response to epidermal growth factor stimulus (GO:0071364) | 2.43567188 |
157 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.43195524 |
158 | modulation by virus of host morphology or physiology (GO:0019048) | 2.41828929 |
159 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.40358291 |
160 | negative regulation of viral release from host cell (GO:1902187) | 2.38200357 |
161 | peptidyl-lysine dimethylation (GO:0018027) | 2.38180326 |
162 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.35900598 |
163 | iron ion import (GO:0097286) | 2.34378031 |
164 | ear development (GO:0043583) | 2.33827046 |
165 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.33448492 |
166 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.33016994 |
167 | surfactant homeostasis (GO:0043129) | 2.32847961 |
168 | histone H3-K9 demethylation (GO:0033169) | 2.32650339 |
169 | cell-cell junction maintenance (GO:0045217) | 2.32401036 |
170 | positive regulation of extracellular matrix organization (GO:1903055) | 2.30650007 |
171 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.30476431 |
172 | cell adhesion mediated by integrin (GO:0033627) | 2.29883128 |
173 | nuclear pore complex assembly (GO:0051292) | 2.29704390 |
174 | trophectodermal cell differentiation (GO:0001829) | 2.28132352 |
175 | regulation of integrin activation (GO:0033623) | 2.26159239 |
176 | histone H3-K4 methylation (GO:0051568) | 2.25770206 |
177 | response to epidermal growth factor (GO:0070849) | 2.22736106 |
178 | regulation of extracellular matrix organization (GO:1903053) | 2.22433494 |
179 | * vesicle coating (GO:0006901) | 2.21207999 |
180 | mitotic chromosome condensation (GO:0007076) | 2.21062772 |
181 | eye morphogenesis (GO:0048592) | 2.20286818 |
182 | negative regulation of myotube differentiation (GO:0010832) | 2.19892990 |
183 | glucose 6-phosphate metabolic process (GO:0051156) | 2.18678897 |
184 | modulation by symbiont of host cellular process (GO:0044068) | 2.17288119 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.24086510 |
2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.79215294 |
3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.40465448 |
4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.13754886 |
5 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.40109625 |
6 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.18636022 |
7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.78647015 |
8 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.77461540 |
9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.57050071 |
10 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.52023534 |
11 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.51887146 |
12 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.45819115 |
13 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.35422262 |
14 | MYC_22102868_ChIP-Seq_BL_Human | 2.12168084 |
15 | GATA1_22025678_ChIP-Seq_K562_Human | 2.10174914 |
16 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.08859766 |
17 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.99176628 |
18 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.92932035 |
19 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.85268250 |
20 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.84218473 |
21 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.72222889 |
22 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.71312529 |
23 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.63432868 |
24 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.63127182 |
25 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.62963341 |
26 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.61677272 |
27 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.60853229 |
28 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.56140805 |
29 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.55932214 |
30 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.52231932 |
31 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.50458399 |
32 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.48291560 |
33 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.46693438 |
34 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.46159007 |
35 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.45338051 |
36 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.43437658 |
37 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.42201772 |
38 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.41951644 |
39 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.41516936 |
40 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.39071049 |
41 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.38805165 |
42 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.37529536 |
43 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.36651048 |
44 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.35453036 |
45 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.35423723 |
46 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.34370990 |
47 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.33549986 |
48 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.32581491 |
49 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.32562132 |
50 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.31150450 |
51 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.31073891 |
52 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.30890642 |
53 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.30837543 |
54 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.30473153 |
55 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.28485601 |
56 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.27714889 |
57 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.26106814 |
58 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.25077677 |
59 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.24942119 |
60 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.24073013 |
61 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.23221428 |
62 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.23221428 |
63 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.22746196 |
64 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.21789035 |
65 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.21625338 |
66 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.20841686 |
67 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.20670899 |
68 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.19487211 |
69 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.19442675 |
70 | * P68_20966046_ChIP-Seq_HELA_Human | 1.17634295 |
71 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.17426772 |
72 | ATF3_27146783_Chip-Seq_COLON_Human | 1.17188843 |
73 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.16810799 |
74 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.16029514 |
75 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.14340415 |
76 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.14200420 |
77 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.14055652 |
78 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.13781188 |
79 | MAF_26560356_Chip-Seq_TH2_Human | 1.13558718 |
80 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.12667633 |
81 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11849586 |
82 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.11849291 |
83 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.11785035 |
84 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.11667835 |
85 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.11570348 |
86 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.11088368 |
87 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.10785959 |
88 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.10623352 |
89 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.10482382 |
90 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.10110957 |
91 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.08078969 |
92 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.07636282 |
93 | GATA1_19941826_ChIP-Seq_K562_Human | 1.07130704 |
94 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.07054723 |
95 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.07054723 |
96 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.06140840 |
97 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.05198593 |
98 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.05171892 |
99 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.04759682 |
100 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.04238585 |
101 | UTX_26944678_Chip-Seq_JUKART_Human | 1.04074636 |
102 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.03810819 |
103 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.03657635 |
104 | KDM2B_26808549_Chip-Seq_K562_Human | 1.03403871 |
105 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.03384978 |
106 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.03114204 |
107 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.02429429 |
108 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.02387807 |
109 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.02098080 |
110 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.01999223 |
111 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01749123 |
112 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.01427006 |
113 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.99800232 |
114 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 0.99526131 |
115 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.98737910 |
116 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.98577614 |
117 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.98388349 |
118 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.98350329 |
119 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.97099361 |
120 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.97084382 |
121 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.95893131 |
122 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.95830205 |
123 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.95193992 |
124 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.94093274 |
125 | MAF_26560356_Chip-Seq_TH1_Human | 0.92456407 |
126 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.91908053 |
127 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.91750537 |
128 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.91217800 |
129 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.91013054 |
130 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.89413194 |
131 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.87705720 |
132 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.87023312 |
133 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.86100623 |
134 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.85929076 |
135 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.85527535 |
136 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.85515205 |
137 | MYB_26560356_Chip-Seq_TH1_Human | 0.85498566 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 4.94830030 |
2 | MP0005360_urolithiasis | 4.37724951 |
3 | MP0005365_abnormal_bile_salt | 4.35636026 |
4 | MP0003705_abnormal_hypodermis_morpholog | 3.63283640 |
5 | MP0005085_abnormal_gallbladder_physiolo | 3.56861264 |
6 | MP0003252_abnormal_bile_duct | 3.55477997 |
7 | MP0005451_abnormal_body_composition | 2.85375390 |
8 | MP0005409_darkened_coat_color | 2.67724724 |
9 | MP0003300_gastrointestinal_ulcer | 2.54494455 |
10 | MP0010329_abnormal_lipoprotein_level | 2.40622574 |
11 | MP0008875_abnormal_xenobiotic_pharmacok | 2.38266742 |
12 | MP0001666_abnormal_nutrient_absorption | 2.28402754 |
13 | MP0010234_abnormal_vibrissa_follicle | 2.22765052 |
14 | MP0004858_abnormal_nervous_system | 2.14249390 |
15 | MP0009840_abnormal_foam_cell | 2.11878876 |
16 | MP0004233_abnormal_muscle_weight | 2.10724004 |
17 | MP0004264_abnormal_extraembryonic_tissu | 2.06528304 |
18 | MP0002796_impaired_skin_barrier | 2.03008460 |
19 | MP0005076_abnormal_cell_differentiation | 2.02957029 |
20 | MP0010352_gastrointestinal_tract_polyps | 1.97960129 |
21 | MP0002877_abnormal_melanocyte_morpholog | 1.97415866 |
22 | MP0005083_abnormal_biliary_tract | 1.89559265 |
23 | MP0002009_preneoplasia | 1.88674397 |
24 | MP0000609_abnormal_liver_physiology | 1.80933473 |
25 | MP0003868_abnormal_feces_composition | 1.69373066 |
26 | MP0005220_abnormal_exocrine_pancreas | 1.68019243 |
27 | MP0001348_abnormal_lacrimal_gland | 1.65351055 |
28 | MP0005670_abnormal_white_adipose | 1.59285606 |
29 | MP0008260_abnormal_autophagy | 1.58185332 |
30 | MP0008438_abnormal_cutaneous_collagen | 1.56700037 |
31 | MP0009780_abnormal_chondrocyte_physiolo | 1.55126089 |
32 | MP0008961_abnormal_basal_metabolism | 1.54044761 |
33 | MP0000569_abnormal_digit_pigmentation | 1.53294476 |
34 | MP0002138_abnormal_hepatobiliary_system | 1.48018208 |
35 | MP0001873_stomach_inflammation | 1.45903656 |
36 | MP0004381_abnormal_hair_follicle | 1.45151453 |
37 | MP0002396_abnormal_hematopoietic_system | 1.41332971 |
38 | MP0002118_abnormal_lipid_homeostasis | 1.40436247 |
39 | MP0003566_abnormal_cell_adhesion | 1.39102714 |
40 | MP0002928_abnormal_bile_duct | 1.36602207 |
41 | MP0004808_abnormal_hematopoietic_stem | 1.36412037 |
42 | MP0009278_abnormal_bone_marrow | 1.35623754 |
43 | MP0003195_calcinosis | 1.35252771 |
44 | MP0003191_abnormal_cellular_cholesterol | 1.34534329 |
45 | MP0004272_abnormal_basement_membrane | 1.34073599 |
46 | MP0004185_abnormal_adipocyte_glucose | 1.33426544 |
47 | MP0003806_abnormal_nucleotide_metabolis | 1.30589570 |
48 | MP0005501_abnormal_skin_physiology | 1.30091930 |
49 | MP0005332_abnormal_amino_acid | 1.30036872 |
50 | MP0003763_abnormal_thymus_physiology | 1.29740577 |
51 | MP0000579_abnormal_nail_morphology | 1.29628568 |
52 | MP0001216_abnormal_epidermal_layer | 1.28259930 |
53 | MP0005666_abnormal_adipose_tissue | 1.27451410 |
54 | MP0003045_fibrosis | 1.27365264 |
55 | MP0000858_altered_metastatic_potential | 1.25823404 |
56 | MP0001944_abnormal_pancreas_morphology | 1.25549669 |
57 | MP0004782_abnormal_surfactant_physiolog | 1.24938786 |
58 | MP0002098_abnormal_vibrissa_morphology | 1.24881129 |
59 | MP0005623_abnormal_meninges_morphology | 1.24205207 |
60 | MP0002089_abnormal_postnatal_growth/wei | 1.23545577 |
61 | MP0001958_emphysema | 1.21196049 |
62 | MP0003283_abnormal_digestive_organ | 1.18962981 |
63 | MP0003436_decreased_susceptibility_to | 1.18171684 |
64 | MP0002166_altered_tumor_susceptibility | 1.17770659 |
65 | MP0005621_abnormal_cell_physiology | 1.15554078 |
66 | MP0009643_abnormal_urine_homeostasis | 1.15156843 |
67 | MP0000678_abnormal_parathyroid_gland | 1.14321607 |
68 | MP0010368_abnormal_lymphatic_system | 1.13370246 |
69 | MP0000003_abnormal_adipose_tissue | 1.12303263 |
70 | MP0005375_adipose_tissue_phenotype | 1.12135460 |
71 | MP0002254_reproductive_system_inflammat | 1.12113985 |
72 | MP0004130_abnormal_muscle_cell | 1.12105950 |
73 | MP0002249_abnormal_larynx_morphology | 1.11664448 |
74 | MP0005319_abnormal_enzyme/_coenzyme | 1.11269691 |
75 | MP0005023_abnormal_wound_healing | 1.11233548 |
76 | MP0002909_abnormal_adrenal_gland | 1.10714648 |
77 | MP0000598_abnormal_liver_morphology | 1.08826322 |
78 | MP0002078_abnormal_glucose_homeostasis | 1.08506369 |
79 | MP0005275_abnormal_skin_tensile | 1.07473496 |
80 | MP0009672_abnormal_birth_weight | 1.07218745 |
81 | MP0005248_abnormal_Harderian_gland | 1.04587189 |
82 | MP0000467_abnormal_esophagus_morphology | 1.03259639 |
83 | MP0006054_spinal_hemorrhage | 1.02527073 |
84 | MP0002693_abnormal_pancreas_physiology | 1.02462826 |
85 | MP0009931_abnormal_skin_appearance | 1.01817081 |
86 | MP0002896_abnormal_bone_mineralization | 1.01557203 |
87 | MP0001730_embryonic_growth_arrest | 1.00839258 |
88 | MP0002168_other_aberrant_phenotype | 1.00381273 |
89 | MP0002006_tumorigenesis | 0.99876717 |
90 | MP0000377_abnormal_hair_follicle | 0.99594647 |
91 | MP0005310_abnormal_salivary_gland | 0.99084366 |
92 | MP0009053_abnormal_anal_canal | 0.95048130 |
93 | MP0000627_abnormal_mammary_gland | 0.94839323 |
94 | MP0009384_cardiac_valve_regurgitation | 0.93031492 |
95 | MP0010307_abnormal_tumor_latency | 0.91912489 |
96 | MP0004019_abnormal_vitamin_homeostasis | 0.91263568 |
97 | MP0001849_ear_inflammation | 0.87797222 |
98 | MP0002060_abnormal_skin_morphology | 0.87155253 |
99 | MP0003172_abnormal_lysosome_physiology | 0.81887191 |
100 | MP0010678_abnormal_skin_adnexa | 0.80313925 |
101 | MP0005334_abnormal_fat_pad | 0.80274499 |
102 | MP0002998_abnormal_bone_remodeling | 0.79698577 |
103 | MP0000566_synostosis | 0.79297566 |
104 | MP0001915_intracranial_hemorrhage | 0.78984901 |
105 | MP0001756_abnormal_urination | 0.78313141 |
106 | MP0009703_decreased_birth_body | 0.77958189 |
107 | MP0004947_skin_inflammation | 0.76189380 |
108 | MP0003091_abnormal_cell_migration | 0.75346808 |
109 | MP0005187_abnormal_penis_morphology | 0.75325619 |
110 | MP0006138_congestive_heart_failure | 0.73690435 |
111 | MP0004197_abnormal_fetal_growth/weight/ | 0.73643036 |
112 | MP0003115_abnormal_respiratory_system | 0.72375267 |
113 | MP0002925_abnormal_cardiovascular_devel | 0.72319992 |
114 | MP0010155_abnormal_intestine_physiology | 0.71862330 |
115 | MP0005380_embryogenesis_phenotype | 0.71333846 |
116 | MP0001672_abnormal_embryogenesis/_devel | 0.71333846 |
117 | MP0002086_abnormal_extraembryonic_tissu | 0.70791266 |
118 | MP0003303_peritoneal_inflammation | 0.70332518 |
119 | MP0000350_abnormal_cell_proliferation | 0.70206063 |
120 | MP0001661_extended_life_span | 0.69966655 |
121 | MP0002080_prenatal_lethality | 0.69676006 |
122 | MP0003183_abnormal_peptide_metabolism | 0.68313352 |
123 | MP0003329_amyloid_beta_deposits | 0.68026270 |
124 | MP0002971_abnormal_brown_adipose | 0.67114767 |
125 | MP0002088_abnormal_embryonic_growth/wei | 0.66608453 |
126 | MP0003279_aneurysm | 0.66603311 |
127 | MP0000462_abnormal_digestive_system | 0.66571947 |
128 | MP0005384_cellular_phenotype | 0.66070838 |
129 | MP0000733_abnormal_muscle_development | 0.65982919 |
130 | MP0001851_eye_inflammation | 0.65594389 |
131 | MP0010771_integument_phenotype | 0.65264731 |
132 | MP0002108_abnormal_muscle_morphology | 0.64973267 |
133 | MP0000371_diluted_coat_color | 0.64887043 |
134 | MP0010630_abnormal_cardiac_muscle | 0.64597538 |
135 | MP0005448_abnormal_energy_balance | 0.64284094 |
136 | MP0003984_embryonic_growth_retardation | 0.64049233 |
137 | MP0000477_abnormal_intestine_morphology | 0.63696225 |
138 | MP0002269_muscular_atrophy | 0.63305123 |
139 | MP0000534_abnormal_ureter_morphology | 0.62602526 |
140 | MP0000767_abnormal_smooth_muscle | 0.62552109 |
141 | MP0000013_abnormal_adipose_tissue | 0.61664842 |
142 | MP0002970_abnormal_white_adipose | 0.61288263 |
143 | MP0009115_abnormal_fat_cell | 0.61091481 |
144 | MP0003453_abnormal_keratinocyte_physiol | 0.60578560 |
145 | MP0002837_dystrophic_cardiac_calcinosis | 0.60189047 |
146 | MP0003890_abnormal_embryonic-extraembry | 0.58620842 |
147 | MP0005058_abnormal_lysosome_morphology | 0.58538998 |
148 | MP0005257_abnormal_intraocular_pressure | 0.58396623 |
149 | MP0009763_increased_sensitivity_to | 0.57946512 |
150 | MP0000537_abnormal_urethra_morphology | 0.57563081 |
151 | MP0005647_abnormal_sex_gland | 0.57022340 |
152 | MP0001243_abnormal_dermal_layer | 0.55459836 |
153 | MP0009642_abnormal_blood_homeostasis | 0.55336101 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Deep venous thrombosis (HP:0002625) | 4.39676068 |
2 | Intrahepatic cholestasis (HP:0001406) | 4.15704565 |
3 | Broad face (HP:0000283) | 3.88218658 |
4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.81712341 |
5 | Hypoglycemic coma (HP:0001325) | 3.59721082 |
6 | Xanthomatosis (HP:0000991) | 3.57939300 |
7 | Abnormality of the common coagulation pathway (HP:0010990) | 3.36671314 |
8 | Complement deficiency (HP:0004431) | 3.36012747 |
9 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.26823380 |
10 | Flat acetabular roof (HP:0003180) | 3.18225586 |
11 | Hypoglycemic seizures (HP:0002173) | 3.16659815 |
12 | Abnormality of the intrinsic pathway (HP:0010989) | 3.10065807 |
13 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.03439448 |
14 | Obstructive sleep apnea (HP:0002870) | 2.97052207 |
15 | Myocardial infarction (HP:0001658) | 2.93761983 |
16 | Cerebral aneurysm (HP:0004944) | 2.92766786 |
17 | Epidermoid cyst (HP:0200040) | 2.91063697 |
18 | Hypobetalipoproteinemia (HP:0003563) | 2.87163555 |
19 | Hyperglycemia (HP:0003074) | 2.85598039 |
20 | Ketosis (HP:0001946) | 2.81962314 |
21 | Premature rupture of membranes (HP:0001788) | 2.73509276 |
22 | Sparse lateral eyebrow (HP:0005338) | 2.68726232 |
23 | Ketoacidosis (HP:0001993) | 2.68361852 |
24 | Hypoalphalipoproteinemia (HP:0003233) | 2.67576132 |
25 | Abnormality of the fingertips (HP:0001211) | 2.66410804 |
26 | Aneurysm (HP:0002617) | 2.65392184 |
27 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.63217743 |
28 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.60451306 |
29 | Hypolipoproteinemia (HP:0010981) | 2.59286205 |
30 | Skin nodule (HP:0200036) | 2.58559442 |
31 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.56223189 |
32 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.56223189 |
33 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.51573987 |
34 | Abnormality of complement system (HP:0005339) | 2.49563965 |
35 | Conjugated hyperbilirubinemia (HP:0002908) | 2.43080089 |
36 | Prolonged partial thromboplastin time (HP:0003645) | 2.43052798 |
37 | Macroorchidism (HP:0000053) | 2.41277838 |
38 | Esophageal varix (HP:0002040) | 2.38147064 |
39 | Asymmetry of the thorax (HP:0001555) | 2.36914444 |
40 | Aortic aneurysm (HP:0004942) | 2.35872058 |
41 | Atrophic scars (HP:0001075) | 2.35764117 |
42 | Hyperlipoproteinemia (HP:0010980) | 2.35745097 |
43 | Advanced eruption of teeth (HP:0006288) | 2.34632873 |
44 | Fat malabsorption (HP:0002630) | 2.31159744 |
45 | Long eyelashes (HP:0000527) | 2.28586081 |
46 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.26836153 |
47 | Mitral valve prolapse (HP:0001634) | 2.26090193 |
48 | Long palpebral fissure (HP:0000637) | 2.25888899 |
49 | Protrusio acetabuli (HP:0003179) | 2.24547776 |
50 | Distal lower limb amyotrophy (HP:0008944) | 2.22274705 |
51 | Mitral stenosis (HP:0001718) | 2.22200638 |
52 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.21586602 |
53 | Fragile skin (HP:0001030) | 2.19469230 |
54 | Hepatocellular carcinoma (HP:0001402) | 2.17636519 |
55 | Short nail (HP:0001799) | 2.17381271 |
56 | Ankyloglossia (HP:0010296) | 2.16764165 |
57 | Long toe (HP:0010511) | 2.16541724 |
58 | Symptomatic seizures (HP:0011145) | 2.15873913 |
59 | Hyperammonemia (HP:0001987) | 2.13539928 |
60 | Lymphangioma (HP:0100764) | 2.12952070 |
61 | Hand muscle atrophy (HP:0009130) | 2.12270015 |
62 | Hypercholesterolemia (HP:0003124) | 2.09831446 |
63 | Late onset (HP:0003584) | 2.07486163 |
64 | Increased connective tissue (HP:0009025) | 2.06772608 |
65 | Dislocated radial head (HP:0003083) | 2.06748036 |
66 | Arterial tortuosity (HP:0005116) | 2.05880940 |
67 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.05475973 |
68 | Osteolytic defects of the hand bones (HP:0009699) | 2.05475973 |
69 | Natal tooth (HP:0000695) | 2.04639250 |
70 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.04105453 |
71 | Dysmetric saccades (HP:0000641) | 2.03923253 |
72 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.01350589 |
73 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.99462488 |
74 | Turricephaly (HP:0000262) | 1.98592712 |
75 | Spastic diplegia (HP:0001264) | 1.97827246 |
76 | Abnormality of purine metabolism (HP:0004352) | 1.97573900 |
77 | Blue sclerae (HP:0000592) | 1.97302732 |
78 | Abnormality of oral frenula (HP:0000190) | 1.97104741 |
79 | Germ cell neoplasia (HP:0100728) | 1.96658749 |
80 | Abnormal ossification of hand bones (HP:0005921) | 1.96443536 |
81 | Vertebral compression fractures (HP:0002953) | 1.94161081 |
82 | Syringomyelia (HP:0003396) | 1.93604793 |
83 | Spinal cord lesions (HP:0100561) | 1.93604793 |
84 | Pseudobulbar signs (HP:0002200) | 1.92770266 |
85 | Abnormality of the radial head (HP:0003995) | 1.92757150 |
86 | Achilles tendon contracture (HP:0001771) | 1.92481328 |
87 | Hyperglycinuria (HP:0003108) | 1.92026798 |
88 | Back pain (HP:0003418) | 1.92016061 |
89 | Joint hemorrhage (HP:0005261) | 1.91798599 |
90 | Vascular tortuosity (HP:0004948) | 1.91540296 |
91 | Subacute progressive viral hepatitis (HP:0006572) | 1.90951432 |
92 | Distal upper limb amyotrophy (HP:0007149) | 1.90946365 |
93 | Upper limb amyotrophy (HP:0009129) | 1.90946365 |
94 | Patellar dislocation (HP:0002999) | 1.90682434 |
95 | Shallow orbits (HP:0000586) | 1.88965674 |
96 | Milia (HP:0001056) | 1.88614539 |
97 | Persistence of primary teeth (HP:0006335) | 1.85848484 |
98 | Abnormality of the Achilles tendon (HP:0005109) | 1.83851507 |
99 | Insulin resistance (HP:0000855) | 1.83495856 |
100 | Abnormality of carpal bone ossification (HP:0006257) | 1.83111225 |
101 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.81816437 |
102 | Mucopolysacchariduria (HP:0008155) | 1.81816437 |
103 | Hemorrhage of the eye (HP:0011885) | 1.81256117 |
104 | Wormian bones (HP:0002645) | 1.80551958 |
105 | Genu recurvatum (HP:0002816) | 1.78453198 |
106 | Lip pit (HP:0100267) | 1.78135368 |
107 | Abnormality of the thoracic spine (HP:0100711) | 1.77970460 |
108 | Hypoplastic ischia (HP:0003175) | 1.77577635 |
109 | Absent frontal sinuses (HP:0002688) | 1.77549603 |
110 | Joint laxity (HP:0001388) | 1.77317889 |
111 | Gout (HP:0001997) | 1.76686034 |
112 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.76320457 |
113 | Heterotopia (HP:0002282) | 1.75091169 |
114 | Abnormality of the ischium (HP:0003174) | 1.74896771 |
115 | Abnormality of nucleobase metabolism (HP:0010932) | 1.74739184 |
116 | Right ventricular cardiomyopathy (HP:0011663) | 1.74238320 |
117 | Abnormality of the phalanges of the hallux (HP:0010057) | 1.74052382 |
118 | Hyperglycinemia (HP:0002154) | 1.73267001 |
119 | Mitral regurgitation (HP:0001653) | 1.72203550 |
120 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.72023697 |
121 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.72023697 |
122 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.72023697 |
123 | Abnormality of glycine metabolism (HP:0010895) | 1.71420914 |
124 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.71420914 |
125 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.70348127 |
126 | Biconcave vertebral bodies (HP:0004586) | 1.70048206 |
127 | Enlarged penis (HP:0000040) | 1.69999643 |
128 | J-shaped sella turcica (HP:0002680) | 1.69536177 |
129 | Interstitial pulmonary disease (HP:0006530) | 1.68707071 |
130 | Septate vagina (HP:0001153) | 1.67678536 |
131 | Precocious puberty (HP:0000826) | 1.67409135 |
132 | Distal lower limb muscle weakness (HP:0009053) | 1.67291448 |
133 | Abnormality of proline metabolism (HP:0010907) | 1.66296160 |
134 | Hydroxyprolinuria (HP:0003080) | 1.66296160 |
135 | Ulnar bowing (HP:0003031) | 1.65986063 |
136 | Bladder diverticulum (HP:0000015) | 1.65167064 |
137 | Ectopia lentis (HP:0001083) | 1.64377139 |
138 | Protuberant abdomen (HP:0001538) | 1.64162605 |
139 | Hematochezia (HP:0002573) | 1.63268465 |
140 | Cervical subluxation (HP:0003308) | 1.62883251 |
141 | Thin bony cortex (HP:0002753) | 1.62294946 |
142 | Narrow palate (HP:0000189) | 1.62164139 |
143 | Urethral obstruction (HP:0000796) | 1.61536600 |
144 | Hyperacusis (HP:0010780) | 1.61167967 |
145 | Dilatation of the ascending aorta (HP:0005111) | 1.60397897 |
146 | Severe short stature (HP:0003510) | 1.60215532 |
147 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.60056280 |
148 | Hyperparathyroidism (HP:0000843) | 1.60016415 |
149 | Bronchomalacia (HP:0002780) | 1.59344491 |
150 | Disproportionate tall stature (HP:0001519) | 1.59278620 |
151 | Peritonitis (HP:0002586) | 1.59153171 |
152 | Spinal rigidity (HP:0003306) | 1.59090859 |
153 | Abdominal distention (HP:0003270) | 1.57565003 |
154 | Overgrowth (HP:0001548) | 1.56518710 |
155 | Abnormality of nail color (HP:0100643) | 1.56513218 |
156 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.56408236 |
157 | Renovascular hypertension (HP:0100817) | 1.55662671 |
158 | Cortical dysplasia (HP:0002539) | 1.55464133 |
159 | Abnormality of the 4th metacarpal (HP:0010012) | 1.55363410 |
160 | Ankle contracture (HP:0006466) | 1.54889472 |
161 | Striae distensae (HP:0001065) | 1.54835591 |
162 | Neonatal death (HP:0003811) | 1.54729324 |
163 | Aortic dissection (HP:0002647) | 1.54219378 |
164 | Insomnia (HP:0100785) | 1.53969265 |
165 | Vertebral arch anomaly (HP:0008438) | 1.53006379 |
166 | Self-mutilation (HP:0000742) | 1.52816556 |
167 | Cerebral inclusion bodies (HP:0100314) | 1.52102849 |
168 | Increased variability in muscle fiber diameter (HP:0003557) | 1.51509532 |
169 | Abnormal foot bone ossification (HP:0010675) | 1.51444252 |
170 | Deformed sella turcica (HP:0002681) | 1.51007194 |
171 | Atelectasis (HP:0100750) | 1.48745510 |
172 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.48613407 |
173 | Ureteral stenosis (HP:0000071) | 1.48350716 |
174 | Arnold-Chiari malformation (HP:0002308) | 1.46805745 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ERN1 | 3.66063061 |
2 | LATS1 | 3.59581863 |
3 | SMG1 | 3.40615366 |
4 | TRIB3 | 3.34099861 |
5 | SIK1 | 3.03001447 |
6 | TAOK3 | 2.90690147 |
7 | PKN2 | 2.88886230 |
8 | CDK12 | 2.88715371 |
9 | PRPF4B | 2.77736798 |
10 | EEF2K | 2.30937774 |
11 | CAMK1D | 2.29579591 |
12 | INSRR | 2.23081070 |
13 | MAP3K10 | 2.21748241 |
14 | RIPK1 | 2.17427602 |
15 | FGFR4 | 2.16574243 |
16 | PTK6 | 2.10915267 |
17 | FRK | 2.01947100 |
18 | CAMK1G | 1.95189343 |
19 | IRAK3 | 1.88661967 |
20 | PDGFRA | 1.79964353 |
21 | FLT3 | 1.67472347 |
22 | TTN | 1.65605678 |
23 | MTOR | 1.51326360 |
24 | JAK1 | 1.37160174 |
25 | BCKDK | 1.34127963 |
26 | SCYL2 | 1.30089968 |
27 | FGFR3 | 1.29483843 |
28 | MAP3K13 | 1.26461052 |
29 | STK3 | 1.19192045 |
30 | ICK | 1.18789217 |
31 | KSR2 | 1.15642878 |
32 | PTK2 | 1.14169379 |
33 | MAP3K7 | 1.10169954 |
34 | EPHA3 | 1.07402766 |
35 | BRD4 | 1.07184064 |
36 | EPHB1 | 1.05030739 |
37 | PASK | 1.03093748 |
38 | TYK2 | 1.00756096 |
39 | RPS6KA2 | 1.00280603 |
40 | PDGFRB | 0.98234966 |
41 | MAP3K2 | 0.96472370 |
42 | CDK6 | 0.96178562 |
43 | MAP4K1 | 0.94526178 |
44 | RIPK4 | 0.93726795 |
45 | JAK3 | 0.93693183 |
46 | SGK3 | 0.93392447 |
47 | STK10 | 0.90106308 |
48 | JAK2 | 0.89348855 |
49 | FGFR2 | 0.87003293 |
50 | TAOK1 | 0.86691983 |
51 | HIPK2 | 0.84768724 |
52 | TGFBR2 | 0.84399779 |
53 | PRKD3 | 0.83630214 |
54 | PRKAA1 | 0.83357472 |
55 | SIK2 | 0.83104271 |
56 | PRKCH | 0.79586617 |
57 | DYRK1B | 0.79003042 |
58 | RET | 0.77597383 |
59 | PAK2 | 0.77319888 |
60 | LRRK2 | 0.75319337 |
61 | TAOK2 | 0.74500652 |
62 | TRPM7 | 0.74409868 |
63 | NUAK1 | 0.72803651 |
64 | PDPK1 | 0.72535595 |
65 | PRKAA2 | 0.72479071 |
66 | CHUK | 0.71991147 |
67 | DDR2 | 0.71235155 |
68 | MAP3K14 | 0.70571151 |
69 | MET | 0.68721439 |
70 | CDK7 | 0.67684774 |
71 | ITK | 0.66915750 |
72 | EPHA2 | 0.66396440 |
73 | MAP3K3 | 0.65479259 |
74 | CDK9 | 0.65268178 |
75 | LATS2 | 0.64410703 |
76 | ERBB4 | 0.64225726 |
77 | RPS6KL1 | 0.64101063 |
78 | RPS6KC1 | 0.64101063 |
79 | FGFR1 | 0.63916479 |
80 | STK38L | 0.63814166 |
81 | TNK2 | 0.61946666 |
82 | BMX | 0.61406852 |
83 | DMPK | 0.59259882 |
84 | SIK3 | 0.59209467 |
85 | MAP3K6 | 0.58661223 |
86 | ZAP70 | 0.58109189 |
87 | PIK3CG | 0.58072961 |
88 | CDC42BPA | 0.57947004 |
89 | CDK4 | 0.56805977 |
90 | IRAK2 | 0.54384031 |
91 | TESK1 | 0.54311808 |
92 | ARAF | 0.53565465 |
93 | AKT3 | 0.53091235 |
94 | NTRK1 | 0.52796633 |
95 | ERBB2 | 0.52709044 |
96 | STK38 | 0.52363405 |
97 | RPS6KB2 | 0.52304848 |
98 | NEK9 | 0.51885399 |
99 | MAP2K2 | 0.51377565 |
100 | MAPK11 | 0.50976500 |
101 | NEK6 | 0.50306799 |
102 | CAMKK1 | 0.49889290 |
103 | NEK2 | 0.49392401 |
104 | MAP2K3 | 0.48890595 |
105 | MAP3K1 | 0.48532549 |
106 | CSF1R | 0.48531048 |
107 | MELK | 0.48410307 |
108 | CSK | 0.48316464 |
109 | MAP3K9 | 0.47385683 |
110 | GSK3A | 0.46005873 |
111 | WNK1 | 0.43799349 |
112 | SGK2 | 0.43128987 |
113 | ALK | 0.42728621 |
114 | RPS6KA4 | 0.42447880 |
115 | FER | 0.42025510 |
116 | PIM2 | 0.41907541 |
117 | PDK1 | 0.41543408 |
118 | RPS6KA6 | 0.41537566 |
119 | MST1R | 0.41246939 |
120 | MARK2 | 0.40489174 |
121 | PAK3 | 0.40362362 |
122 | PRKD1 | 0.39603934 |
123 | TYRO3 | 0.37913134 |
124 | TBK1 | 0.37766954 |
125 | MAP3K8 | 0.36369093 |
126 | EGFR | 0.35806730 |
127 | MAPK10 | 0.34738658 |
128 | GRK6 | 0.34578506 |
129 | LMTK2 | 0.34230040 |
130 | PAK4 | 0.33766944 |
131 | IRAK4 | 0.33649346 |
132 | MAPK1 | 0.33239738 |
133 | PRKD2 | 0.32378279 |
134 | IGF1R | 0.31619978 |
135 | MAPKAPK3 | 0.30282994 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.51144996 |
2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.96901314 |
3 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.82571732 |
4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.74944118 |
5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.54388019 |
6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.44716753 |
7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.20160950 |
8 | Lysine degradation_Homo sapiens_hsa00310 | 2.11269013 |
9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.04332974 |
10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.03340720 |
11 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.99251501 |
12 | Other glycan degradation_Homo sapiens_hsa00511 | 1.88375809 |
13 | Thyroid cancer_Homo sapiens_hsa05216 | 1.71648061 |
14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.69382948 |
15 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.66461165 |
16 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.63834837 |
17 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.62671182 |
18 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.61440374 |
19 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.59810516 |
20 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.57865839 |
21 | ABC transporters_Homo sapiens_hsa02010 | 1.50711258 |
22 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.47109672 |
23 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.46916757 |
24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.44983723 |
25 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.42449084 |
26 | Insulin resistance_Homo sapiens_hsa04931 | 1.42226692 |
27 | Bile secretion_Homo sapiens_hsa04976 | 1.41140400 |
28 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.40846992 |
29 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.40374683 |
30 | Glioma_Homo sapiens_hsa05214 | 1.37695119 |
31 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.37175926 |
32 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.34507370 |
33 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.33548641 |
34 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.32612462 |
35 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.31985997 |
36 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.30368323 |
37 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.29884272 |
38 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.28839372 |
39 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.27302122 |
40 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.25205644 |
41 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.22336285 |
42 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.22300198 |
43 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.20647962 |
44 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.20633327 |
45 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.16862710 |
46 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.16013673 |
47 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.14631057 |
48 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.13931776 |
49 | Hepatitis C_Homo sapiens_hsa05160 | 1.11598838 |
50 | Hepatitis B_Homo sapiens_hsa05161 | 1.11241362 |
51 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.08695400 |
52 | Colorectal cancer_Homo sapiens_hsa05210 | 1.03192243 |
53 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.01840742 |
54 | Peroxisome_Homo sapiens_hsa04146 | 0.99151216 |
55 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.99095008 |
56 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.98559944 |
57 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.97443670 |
58 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.96378909 |
59 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.94015456 |
60 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.93702820 |
61 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.92194013 |
62 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.92002136 |
63 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.89258467 |
64 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.87643822 |
65 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.87355803 |
66 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.86613947 |
67 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.86535808 |
68 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.86041556 |
69 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.85954871 |
70 | Influenza A_Homo sapiens_hsa05164 | 0.85397845 |
71 | Histidine metabolism_Homo sapiens_hsa00340 | 0.85069162 |
72 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.84727115 |
73 | Adherens junction_Homo sapiens_hsa04520 | 0.84183582 |
74 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.83248699 |
75 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.82279389 |
76 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.82191316 |
77 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.80399931 |
78 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.76606248 |
79 | Apoptosis_Homo sapiens_hsa04210 | 0.76569286 |
80 | Carbon metabolism_Homo sapiens_hsa01200 | 0.76287562 |
81 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.75875788 |
82 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.75832517 |
83 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.75418880 |
84 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.75305236 |
85 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.74444965 |
86 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.74076654 |
87 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.72545514 |
88 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.72216952 |
89 | Retinol metabolism_Homo sapiens_hsa00830 | 0.71279297 |
90 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.70618646 |
91 | Endocytosis_Homo sapiens_hsa04144 | 0.70607699 |
92 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.69271741 |
93 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.69267734 |
94 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.68406154 |
95 | HTLV-I infection_Homo sapiens_hsa05166 | 0.65719190 |
96 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.65647666 |
97 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.65333930 |
98 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.64673855 |
99 | Measles_Homo sapiens_hsa05162 | 0.64363495 |
100 | Long-term potentiation_Homo sapiens_hsa04720 | 0.63833519 |
101 | Platelet activation_Homo sapiens_hsa04611 | 0.63241324 |
102 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.63179521 |
103 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.62860169 |
104 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.61829177 |
105 | Pathways in cancer_Homo sapiens_hsa05200 | 0.61731128 |
106 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.61657410 |
107 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.60059472 |
108 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.59814734 |
109 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.59561705 |
110 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.58595083 |
111 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.58566067 |
112 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.58027193 |
113 | Focal adhesion_Homo sapiens_hsa04510 | 0.57350327 |
114 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.56636816 |
115 | Endometrial cancer_Homo sapiens_hsa05213 | 0.55875381 |
116 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.55665402 |
117 | Melanoma_Homo sapiens_hsa05218 | 0.54795110 |
118 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.54545084 |
119 | Galactose metabolism_Homo sapiens_hsa00052 | 0.54534591 |
120 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.53401084 |
121 | Melanogenesis_Homo sapiens_hsa04916 | 0.53219895 |
122 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.53101256 |
123 | Shigellosis_Homo sapiens_hsa05131 | 0.52588380 |
124 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.52164679 |
125 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.51945199 |
126 | Lysosome_Homo sapiens_hsa04142 | 0.51549461 |
127 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.51267985 |
128 | Prostate cancer_Homo sapiens_hsa05215 | 0.51209892 |
129 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.51138523 |
130 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.49824704 |
131 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.49308874 |
132 | Amoebiasis_Homo sapiens_hsa05146 | 0.48425788 |
133 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.48191954 |
134 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.48165997 |
135 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.47334081 |
136 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.46298712 |
137 | Bladder cancer_Homo sapiens_hsa05219 | 0.46111166 |
138 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.45103549 |
139 | Salmonella infection_Homo sapiens_hsa05132 | 0.43984296 |
140 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.43845736 |
141 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.43178175 |
142 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.42812392 |
143 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.42587152 |
144 | Prion diseases_Homo sapiens_hsa05020 | 0.41832951 |
145 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.37967631 |
146 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.37732058 |
147 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.37679096 |
148 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.37251718 |
149 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.37095576 |
150 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.36652862 |
151 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.35866435 |
152 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.34428868 |
153 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.32815498 |
154 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.32504624 |
155 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.29950935 |
156 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.29456309 |
157 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.27724552 |